Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
16,101,341
-
Shares change
-
+790,385
-
Total reported value, excl. options
-
$2,888,001
-
Value change
-
+$61,216
-
Put/Call ratio
-
0%
-
Number of buys
-
11
-
Number of sells
-
-16
-
Price
-
$0.1788
Significant Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q3 2017
42 filings reported holding ARGS - ARGOS THERAPEUTICS INC - COM as of Q3 2017.
ARGOS THERAPEUTICS INC - COM (ARGS) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,101,341 shares
.
Largest 10 shareholders include Pharmstandard International S.A. (13,242,279 shares), VANGUARD GROUP INC (843,927 shares), WASATCH ADVISORS INC (665,831 shares), MILLENNIUM MANAGEMENT LLC (180,032 shares), TWO SIGMA SECURITIES, LLC (149,999 shares), SANDERS MORRIS HARRIS LLC (132,212 shares), GEODE CAPITAL MANAGEMENT, LLC (129,046 shares), KEYBANK NATIONAL ASSOCIATION/OH (119,515 shares), WEDBUSH SECURITIES INC (112,000 shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (94,800 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.